Disclosure 0001193125-26-365202-2

SEC FORM 4

$3,363,750.00

NewAmsterdam Pharma Co N.V. (NAMS)

Sale of 125,000 shares at $26.91 per share.

Reporting Person Kastelein Johannes Jacob Pieter · Officer Title Chief Scientific Officer · Transaction Code S

Traded Aug 24, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0001193125-26-365202 · filed 2026-08-25 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "NewAmsterdam Pharma Co N.V. (NAMS)." Disclosed 2026-08-25. https://desqlong.com/cards/0001193125-26-365202-2 (retrieved 2026-09-26).